<amendment session="116" chamber="h" number="224" updated="2019-05-31T07:16:08Z">
  <amends type="h" number="987" sequence=""/>
  <status datetime="2019-05-16T15:21:54-04:00">pass</status>
  <sponsor bioguide_id="D000623"/>
  <offered datetime="2019-05-16"/>
  <description>An amendment numbered 5 printed in House Report 116-61 to Commission a study by the National Academy of Medicine into the amount of federal funding and research used in the development of drugs by pharmaceutical companies, and to put measures in place to curb excessive drug costs.</description>
  <actions>
    <vote datetime="2019-05-16T15:21:54-04:00" how="by voice vote" result="pass">
      <text>On agreeing to the DeSaulnier amendment (A005) Agreed to by voice vote.</text>
    </vote>
    <action datetime="2019-05-16T15:15:59-04:00">
      <text>Amendment (A005) offered by Mr. DeSaulnier.</text>
      <reference ref="CR H3878-3879" label="consideration"/>
      <reference ref="CR H3878" label="text"/>
    </action>
    <action datetime="2019-05-16"/>
    <action datetime="2019-05-16T15:15:59-04:00">
      <text>House amendment offered/reported by: Amendment (A005) offered by Mr. DeSaulnier.</text>
    </action>
    <action datetime="2019-05-16T15:21:54-04:00">
      <text>Amendment agreed to Committee of the Whole</text>
    </action>
    <action datetime="2019-05-16T15:21:54-04:00">
      <text>House amendment agreed to: On agreeing to the DeSaulnier amendment (A005) Agreed to by voice vote.</text>
    </action>
    <action datetime="2019-05-16">
      <text>House amendment offered</text>
    </action>
  </actions>
</amendment>
